TR200100622T2 - NAB1 ve NAB2'nin farmasötik kullanımları - Google Patents
NAB1 ve NAB2'nin farmasötik kullanımlarıInfo
- Publication number
- TR200100622T2 TR200100622T2 TR2001/00622T TR200100622T TR200100622T2 TR 200100622 T2 TR200100622 T2 TR 200100622T2 TR 2001/00622 T TR2001/00622 T TR 2001/00622T TR 200100622 T TR200100622 T TR 200100622T TR 200100622 T2 TR200100622 T2 TR 200100622T2
- Authority
- TR
- Turkey
- Prior art keywords
- nab1
- nab2
- pharmaceutical uses
- polypeptide
- polypeptides
- Prior art date
Links
- 101000583053 Homo sapiens NGFI-A-binding protein 1 Proteins 0.000 title abstract 2
- 101000583057 Homo sapiens NGFI-A-binding protein 2 Proteins 0.000 title abstract 2
- CZSLEMCYYGEGKP-UHFFFAOYSA-N N-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)benzimidazole-5-carboxamide Chemical compound CC1=CC=C(C)C(N2C3=CC=C(C=C3N=C2)C(=O)NCC=2C(=CC=CC=2)Cl)=C1 CZSLEMCYYGEGKP-UHFFFAOYSA-N 0.000 title abstract 2
- 102100030407 NGFI-A-binding protein 1 Human genes 0.000 title abstract 2
- 102100030391 NGFI-A-binding protein 2 Human genes 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Bulus, insan dahil olmak üzere bir memelide yara iyilesmesi ile birlikte görülen hücre bozukluklarinin iyilestirilmesi için bir tibbi maddenin imalatinda, özellikle gen terapisinde, bir NAB1 yada NAB2 polipeptidi ya da bu polipeptidin biyolojik açidan aktif bir fragmaninin kullanimi ve bu polipeptidleri kodlayan nükleik asit moleküllerine iliskindir.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814989.1A GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
| GBGB9819826.0A GB9819826D0 (en) | 1998-09-12 | 1998-09-12 | Gene therapy method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100622T2 true TR200100622T2 (tr) | 2001-10-22 |
Family
ID=26314007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00622T TR200100622T2 (tr) | 1998-07-11 | 1999-07-09 | NAB1 ve NAB2'nin farmasötik kullanımları |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1097200A1 (tr) |
| JP (1) | JP2002520020A (tr) |
| KR (1) | KR20010071832A (tr) |
| CN (1) | CN1317045A (tr) |
| AP (1) | AP2001002038A0 (tr) |
| AU (1) | AU763713B2 (tr) |
| BR (1) | BR9912018A (tr) |
| CA (1) | CA2336805A1 (tr) |
| EA (1) | EA200100028A1 (tr) |
| EE (1) | EE200100020A (tr) |
| HR (1) | HRP20010025A2 (tr) |
| HU (1) | HUP0102835A3 (tr) |
| ID (1) | ID27742A (tr) |
| IL (1) | IL140533A0 (tr) |
| IS (1) | IS5788A (tr) |
| NO (1) | NO20010166L (tr) |
| NZ (1) | NZ509174A (tr) |
| PL (1) | PL345507A1 (tr) |
| SK (1) | SK382001A3 (tr) |
| TR (1) | TR200100622T2 (tr) |
| WO (1) | WO2000003014A1 (tr) |
| YU (1) | YU1901A (tr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928430D0 (en) * | 1999-12-01 | 2000-01-26 | Glaxo Group Ltd | Screening |
| WO2002022176A1 (en) | 2000-09-15 | 2002-03-21 | Genvec, Inc. | Method of modulating neovascularization |
| WO2004083435A1 (en) * | 2003-03-17 | 2004-09-30 | Julius-Maximilians-Uni Versität Würzburg | Nab proteins and their use in diagnostic and therapeutic applications in heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036006A (en) * | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5697901A (en) * | 1989-12-14 | 1997-12-16 | Elof Eriksson | Gene delivery by microneedle injection |
-
1999
- 1999-07-09 EE EEP200100020A patent/EE200100020A/xx unknown
- 1999-07-09 AP APAP/P/2001/002038A patent/AP2001002038A0/en unknown
- 1999-07-09 IL IL14053399A patent/IL140533A0/xx unknown
- 1999-07-09 AU AU47914/99A patent/AU763713B2/en not_active Ceased
- 1999-07-09 TR TR2001/00622T patent/TR200100622T2/tr unknown
- 1999-07-09 HR HR20010025A patent/HRP20010025A2/hr not_active Application Discontinuation
- 1999-07-09 HU HU0102835A patent/HUP0102835A3/hu unknown
- 1999-07-09 KR KR1020017000413A patent/KR20010071832A/ko not_active Withdrawn
- 1999-07-09 NZ NZ509174A patent/NZ509174A/en unknown
- 1999-07-09 CN CN99810616A patent/CN1317045A/zh active Pending
- 1999-07-09 EP EP99931378A patent/EP1097200A1/en not_active Withdrawn
- 1999-07-09 ID IDW20010345A patent/ID27742A/id unknown
- 1999-07-09 PL PL99345507A patent/PL345507A1/xx not_active Application Discontinuation
- 1999-07-09 EA EA200100028A patent/EA200100028A1/ru unknown
- 1999-07-09 JP JP2000559235A patent/JP2002520020A/ja active Pending
- 1999-07-09 BR BR9912018-6A patent/BR9912018A/pt not_active IP Right Cessation
- 1999-07-09 YU YU1901A patent/YU1901A/sh unknown
- 1999-07-09 WO PCT/GB1999/002199 patent/WO2000003014A1/en not_active Ceased
- 1999-07-09 CA CA002336805A patent/CA2336805A1/en not_active Abandoned
- 1999-07-09 SK SK38-2001A patent/SK382001A3/sk unknown
-
2000
- 2000-12-22 IS IS5788A patent/IS5788A/is unknown
-
2001
- 2001-01-10 NO NO20010166A patent/NO20010166L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK382001A3 (en) | 2001-09-11 |
| AU763713B2 (en) | 2003-07-31 |
| HUP0102835A3 (en) | 2003-09-29 |
| WO2000003014A1 (en) | 2000-01-20 |
| NO20010166L (no) | 2001-03-06 |
| AP2001002038A0 (en) | 2001-03-31 |
| NO20010166D0 (no) | 2001-01-10 |
| KR20010071832A (ko) | 2001-07-31 |
| EE200100020A (et) | 2002-06-17 |
| HUP0102835A2 (hu) | 2001-11-28 |
| IS5788A (is) | 2000-12-22 |
| AU4791499A (en) | 2000-02-01 |
| CN1317045A (zh) | 2001-10-10 |
| NZ509174A (en) | 2003-08-29 |
| HRP20010025A2 (en) | 2001-12-31 |
| EA200100028A1 (ru) | 2001-08-27 |
| BR9912018A (pt) | 2006-01-31 |
| IL140533A0 (en) | 2002-02-10 |
| YU1901A (sh) | 2005-06-10 |
| JP2002520020A (ja) | 2002-07-09 |
| CA2336805A1 (en) | 2000-01-20 |
| ID27742A (id) | 2001-04-26 |
| EP1097200A1 (en) | 2001-05-09 |
| PL345507A1 (en) | 2001-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69738581D1 (de) | Menschliche dnase i hyperaktive varianten | |
| DE60140794D1 (de) | Von casein abgeleitete peptide und deren anwendung für die therapie | |
| DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| DE69429260D1 (de) | Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie | |
| NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
| ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
| ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| ATE191922T1 (de) | Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen | |
| EP1114862A3 (de) | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen | |
| WO2003039591A3 (de) | Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle | |
| ATE123814T1 (de) | Gentechnologische menschliche cholinesterasen. | |
| ATE395602T1 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
| TR199901385T2 (tr) | Piperidin türevleri. | |
| YU1901A (sh) | Upotreba nab1 i nab2 u farmaciji | |
| BR9809712A (pt) | Formas de dosagem de sertralina em solução encapsulada de gelatina | |
| PT1133296E (pt) | Nova aplicacao terapeutica da nicergolina | |
| TR199902866T2 (tr) | Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlari, hazirlanmalari ve terapide kullanilmalari için prosesler. | |
| ATE540968T1 (de) | Alpha-fetoproteinpeptide und deren verwendungen | |
| TR200102265T2 (tr) | Anestezi düzenlemesi. | |
| EP1083927A4 (en) | HUMAN "MINOR VAULT" PROTEIN P193 | |
| ATE230027T1 (de) | Menschliche dnase i varianten | |
| ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| WO2000026362A3 (de) | Proteine der stomatinfamilie und ihre verwendung als zielproteine für die schmerztherapie | |
| ES2188754T3 (es) | Componente b como cicatrizante. | |
| DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff |